Compare ONB & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONB | CRL |
|---|---|---|
| Founded | 1834 | 1947 |
| Country | United States | United States |
| Employees | 5243 | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 8.3B |
| IPO Year | N/A | 1999 |
| Metric | ONB | CRL |
|---|---|---|
| Price | $21.21 | $153.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $26.83 | ★ $197.58 |
| AVG Volume (30 Days) | ★ 2.9M | 970.5K |
| Earning Date | 04-21-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.65% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $27.88 | $2.11 |
| Revenue Next Year | $5.00 | $2.95 |
| P/E Ratio | $13.92 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $16.83 | $91.86 |
| 52 Week High | $26.17 | $228.88 |
| Indicator | ONB | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 28.31 | 36.52 |
| Support Level | $19.93 | $145.97 |
| Resistance Level | $21.65 | $157.42 |
| Average True Range (ATR) | 0.62 | 6.66 |
| MACD | -0.18 | -0.77 |
| Stochastic Oscillator | 14.46 | 16.61 |
Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.